Licensing medicines for HIV/AIDS: critical mechanism for ending the epidemic

Access to Medicine Index, 1 December 2014

Read online at:

For World Aids Day, the Access to Medicine Index has analysed the licensing practices of the top 20 research-based pharmaceutical companies to assess how they are contributing to global efforts to combat HIV/AIDS. Ending the epidemic requires a massive scale up of affordable medicines. Based on this analysis, pharmaceutical companies need to license their HIV/AIDS medicines to more generic medicine manufacturers, in more countries, and earlier in a product’s lifespan.

(Visited 17 times, 1 visits today)
This entry was posted in Essential Medicines, General, HIV - AIDS - STI. Bookmark the permalink.